Search

Gwangseong Kim

from Lexington, MA
Age ~51
Get Report
Also known as:
Kim Gwangseong, Grace Kari
Related to:
Hye Lobert, 75Heeku Kim, 48Myungkyun Kim, 65Jaesoon KimJaesik KimByung KimJennifer N Scheller, 42
Connected to:
Abe Kim, 48Adrienne P Kim, 48Ae J KimAlana M Kim, 27Alissa A Kim, 32Allan H Kim, 55Alton Kim, 67Alvin U Kim, 52Analia Kim, 38Anatole S Kim, 67

Gwangseong Kim Phones & Addresses

  • Lexington, MA
  • Miami, FL
  • 2155 Cram Cir, Ann Arbor, MI 48105 (734) 647-1615

Resumes

Resumes

Gwangseong Kim Photo 1

Chief Technology Officer

View page
Location:
Miami, FL
Industry:
Biotechnology
Work:
Kytaro Inc.
Chief Technology Officer
Kytaro Inc. Apr 2014 - Jun 2015
Senior Research Scientist
University of Michigan Emergency Medicine Akadeum Life Sciences Aug 1, 2013 - Apr 1, 2014
Research Fellow at University of Michigan and Founding Member of Akadeum Life Sciences Llc
University of Michigan Jan 2012 - Jul 2013
Team Leader In Um Pharmaceutical Sciences - Dow Chemical Co-Development Project
University of Michigan May 1, 2008 - Dec 1, 2011
Post-Doc Research Fellow In the Department of Chemistry
Education:
University of Michigan, Ann Arbor 2008
University of Michigan 2003 - 2008
Doctorates, Doctor of Philosophy, Biomedical Engineering, Medical Engineering, Philosophy University of Michigan, Ann Arbor 2001 - 2003
Masters, Biomedical Engineering University of Michigan 2003
Hanyang University 1993 - 2000
Bachelors Hanyang University 2000
Bachelors, Bachelor of Science University of Michigan, Ann Arbor
Doctorates, Doctor of Philosophy University of Michigan, Ann Arbor
Master of Science, Masters
Skills:
Biotechnology
Fluorescence Microscopy
R&D
Drug Delivery
Scanning Electron Microscopy
Cell Culture
Chemistry
Formulation
Nasal Drug Delivery
High Density Lipoproteins
Hplc
Gpc
Polymers
Rheology
Dynamic Light Scattering
Zeta Potential
Isothermal Titration Calorimetry
Drug Permeation
Assay Development
Cell
Nanotechnology
Cell Isolation
Biomaterials
Validation
Nanoparticles
Confocal Microscopy
Commercialization
Uv/Vis
Spectroscopy
Cancer
Dls
Life Sciences
Pcr
Dna Extraction
Hematology
Transfusion Medicine
Food Pathogen Testing
Magnetic Separation
Cell Separation
Infectious Diseases
Drug Resistance
Sepsis
Languages:
English
Korean
Gwangseong Kim Photo 2

Formulation Scientist

View page
Location:
Omaha, NE
Industry:
Biotechnology
Work:
L.e.a.f Pharmaceuticals
Formulation Scientist
Kytaro Inc. Jul 2015 - Jun 2017
Chief Technology Officer
Kytaro Inc. Apr 2014 - Jun 2015
Senior Research Scientist
Akadeum Life Science Aug 2013 - Apr 2014
Interim Chief Technology Officer
University of Michigan Jan 2012 - Jul 2013
Team Leader University of Michigan - Dow Chemical Co-Development Project
Education:
University of Michigan 2003 - 2008
Doctorates, Doctor of Philosophy, Philosophy
Skills:
Cell Culture
Drug Delivery
Biotechnology
R&D
Chemistry
Scanning Electron Microscopy
Nanoparticles
Polymers
Fluorescence Microscopy
Assay Development
Cell
Nanotechnology
Biomaterials
Formulation
Dynamic Light Scattering
Isothermal Titration Calorimetry
Validation
Confocal Microscopy
Cancer
Life Sciences
Nasal Drug Delivery
High Density Lipoproteins
Hplc
Gpc
Rheology
Zeta Potential
Drug Permeation
Cell Isolation
Commercialization
Uv/Vis
Spectroscopy
Dls
Pcr
Dna Extraction
Hematology
Transfusion Medicine
Food Pathogen Testing
Magnetic Separation
Cell Separation
Infectious Diseases
Drug Resistance
Sepsis
Gwangseong Kim Photo 3

Gwangseong Kim Ann Arbor, MI

View page
Work:
College of Pharmacy

Jan 2012 to 2000
Post-doctoral Research Fellow, Professor Steven P. Schwendeman
Department of Chemistry

May 2008 to 2000
Post-doctoral Research Fellow, Professor Raoul Kopelman
Ph.D. program in Biomedical Engineering
Ann Arbor, MI
Apr 2001 to 2008
Development of novel nano
Proctoring

Feb 2005 to 2007
Ph.D. program in Biomedical Engineering

Feb 2004 to 2005
President of Korean Catholic
Ph.D. program in Biomedical Engineering

Mar 2003 to 2004
Leader of Korean Catholic
Military service in Korean Army

Jan 1995 to 1997
Chemical specialist
Ph.D. program in Biomedical Engineering

Apr 2012 to Present
Education:
University of Michigan
Ann Arbor, MI
May 2003 to Apr 2008
Ph.D. of Biomedical Engineering in Biomedical Engineering Department
University of Michigan
Ann Arbor, MI
Sep 2001 to May 2003
Master of Engineering in Biomedical Engineering Department
Hanyang University, College of Engineering
Seoul, KR
Mar 1993 to Feb 2000
Bachelor of Engineering in Engineering, Chemical Engineering
Gwangseong Kim Photo 4

Gwangseong Kim Ann Arbor, MI

View page
Work:
University of Michigan, Ann Arbor, College of Pharmacy

Jan 2012 to 2000
Postdoctoral Research Fellow in Pharmaceutical Sciences
University of Michigan
Ann Arbor, MI
May 2008 to Dec 2011
Post-doctoral Research Fellow, Professor Raoul Kopelman, Department of Chemistry
Education:
University of Michigan
Ann Arbor, MI
May 2003 to Apr 2008
Ph.D. of Biomedical Engineering in Biomedical Engineering Department
University of Michigan
Ann Arbor, MI
Sep 2001 to May 2003
Master of Engineering in Biomedical Engineering
Hanyang University, College of Engineering
Seoul, KR
Mar 1993 to Feb 2000
Bachelor of Engineering in Chemical Engineering
Military:
Rank: Sergeant Jul 1995 to Sep 1997
Branch: ChemicalL.i.location.original
Skills:
1. Synthesis and characterization of various nanomaterials 2. Drug formulation for nasal delivery and actively tissue targeted photodynamic therapy 3. Expertise in reactive oxygen species chemistry, toxicity, sensing methodology 5. Highly rich experiences in microscopy (bright field, fluorescence, confocal, and electorn beam (SEM, TEM)) 6. Highly rich experiences in various analysis techniques (HPLC, fluorescence, UV-VIS, zeta potential, particle sizing (DLS), mass spec, FITR, NMR, etc.) 7. 7 years of experience in cell culture and various bio-analysis assay methods, including cytotoxicity, apoptosis, reactive oxygen detection, cell proliferation, endocytosis, immunohistochemistry, ciliary beating, mucociliary clearance, etc. 8. Rich experience in polymer rheology, drug-polymer interaction, tissue permeation, drug release kinetics 9. Knowledgeable in lasers, tissue optics, medical imaging technology 10. Knowledgeable in biochemistry, Cancer biology, molecular / cellular biology, and human physiology

Publications

Us Patents

Photoacoustic Indicators

View page
US Patent:
20080230717, Sep 25, 2008
Filed:
Mar 18, 2008
Appl. No.:
12/050493
Inventors:
Shai Ashkenazi - Ann Arbor MI, US
Raoul Kopelman - Ann Arbor MI, US
Russell S. Witte - Tucson AZ, US
Thomas D. Horvath - Little Rock AR, US
Gwangseong Kim - Ann Arbor MI, US
International Classification:
G01J 1/58
US Classification:
2504591
Abstract:
A method of measuring fluorophore excited state lifetimes comprising initiating an excitation laser pulse at a dye to excite dye molecules of the dye from a ground state to an excited state and initiating a probing pulse at the dye molecules thereby generating a first set of photoacoustic waves at a first time delay resulting in a first intensity point. The process can be repeated, optionally introducing a second excitation laser pulse, to generate a second set of photoacoustic waves at a second time delay resulting in a second intensity point. The data can be analyzed to determine a slope between the first intensity point and the second intensity point.

Systems And Methods For Targeted Imaging And Ablation Of Cardiac Cells

View page
US Patent:
20200188514, Jun 18, 2020
Filed:
Dec 10, 2019
Appl. No.:
16/708804
Inventors:
- Ann Arbor MI, US
Raoul Kopelman - Ann Arbor MI, US
Uma Mahesh R. Avula - Ypsilanti MI, US
Gwangseong Kim - Ann Arbor MI, US
Yong-Eun Koo Lee - Seoul, KR
Hyung Ki Yoon - Ann Arbor MI, US
International Classification:
A61K 41/00
A61K 38/18
A61K 38/21
A61K 38/20
A61K 38/10
A61K 9/51
A61K 33/24
A61K 31/704
A61K 31/5415
Abstract:
The present invention relates to nanoparticles. In particular, the present invention provides nanoparticles for clinical (e.g., targeted therapeutic), diagnostic (e.g., imaging), and research applications in the field of cardiology. For example, in some embodiments, the present invention provides a method of treating (e.g., ablating) cardiac tissue, comprising: a) contacting an animal with a nanoparticle comprising a matrix, a toxic (e.g., ablative) agent (e.g., sonosensitizer, chemotherapeutic agent (e.g., doxorubicin or cisplatin), or photosensitizer), and a cardiac targeting moiety; and b) administering an activator of the toxic agent (e.g., light, chemical (e.g., pharmaceutical agent) or ultrasound) to at least a portion of the cardiac tissue (e.g., heart) of the animal to activate the toxic agent.

Pre-Concertation Apparatus & Method

View page
US Patent:
20160334312, Nov 17, 2016
Filed:
Jul 28, 2016
Appl. No.:
15/222590
Inventors:
Angelo Gaitas - Miami FL, US
Gwangseong Kim - Miami FL, US
International Classification:
G01N 1/40
B01L 3/00
Abstract:
The present invention relates to concentrating disease causing agents, such as foodborne pathogens, from complex media to expedite their detection. In particular, the present invention relates to a method to pre-concentrate pathogens rapidly, thereby enabling earlier detection times. Primarily, the present invention utilizes an approach that can concentrate the pathogens by flowing a sample through immuno-capturing tubes (“entrapment chamber” or “chamber”) during an early pre-enrichment period. Also, the invention relates to using binding materials to trap disease causing agent that is desired to be removed from the complex media such as the blood of a patient. It also related to using lights of specific wavelength to inactivate pathogens. The light is used to activate reactive oxygen species using a photo-sensitizer or directly kill the pathogen using light of wavelength between 100 nm and 450 nm.

Blood Cleansing And Apparatus & Method

View page
US Patent:
20160058937, Mar 3, 2016
Filed:
Nov 9, 2015
Appl. No.:
14/936112
Inventors:
Angelo Gaitas - Miami FL, US
Gwangseong Kim - Miami FL, US
International Classification:
A61M 1/36
Abstract:
The present invention relates to removing disease causing agent such as pathogens from the blood of a patient. Specifically, the invention relates to using coating materials to trap disease causing agent that is desired to be removed from the blood of a patient. It also related to using lights of specific wavelength to inactivate pathogens. The light is used to activate reactive oxygen species using a photo-sensitizer or directly kill the pathogen using light of wavelength between 100 nm and 450 nm.

Systems And Methods For Targeted Imaging And Ablation Of Cardiac Cells

View page
US Patent:
20150328315, Nov 19, 2015
Filed:
Apr 23, 2013
Appl. No.:
14/396533
Inventors:
- Ann Arbor MI, US
Raoul Kopelman - Ann Arbor MI, US
Uma Mahesh R. Avula - Ypsilanti MI, US
Gwangseong Kim - Ann Arbor MI, US
Yong-Eun Koo Lee - Seoul, KR
Hyung Ki Yoon - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 41/00
A61K 9/51
A61K 33/24
A61K 31/5415
A61K 31/704
Abstract:
The present invention relates to nanoparticles. In particular, the present invention provides nanoparticles for clinical (e.g., targeted therapeutic), diagnostic (e.g., imaging), and research applications in the field of cardiology. For example, in some embodiments, the present invention provides a method of treating (e.g., ablating) cardiac tissue, comprising: a) contacting an animal with a nanoparticle comprising a matrix, a toxic (e.g., ablative) agent (e.g., sonosensitizer, chemotherapeutic agent (e.g., doxorubicin or cisplatin), or photosensitizer), and a cardiac targeting moiety; and b) administering an activator of the toxic agent (e.g., light, chemical (e.g., pharmaceutical agent) or ultrasound) to at least a portion of the cardiac tissue (e.g., heart) of the animal to activate the toxic agent.

Blood Cleansing System

View page
US Patent:
20150121808, May 7, 2015
Filed:
Dec 8, 2014
Appl. No.:
14/564042
Inventors:
Angelo Gaitas - Miami FL, US
Gwangseong Kim - Miami FL, US
International Classification:
A61M 1/36
US Classification:
53431
Abstract:
The present invention relates to removing disease material from the blood of a patient. Specifically, the invention relates to using biological binders to trap disease material that is desired to be removed from the blood of a patient.

Blood Cleansing System & Method

View page
US Patent:
20150122738, May 7, 2015
Filed:
Dec 11, 2014
Appl. No.:
14/567784
Inventors:
Angelo Gaitas - Ann Arbor MI, US
Gwangseong Kim - Miami FL, US
International Classification:
A61M 1/36
A61K 41/00
US Classification:
210662, 210668
Abstract:
The present invention relates to removing disease material from the blood of a patient. Specifically, the invention relates to using biological binders to trap disease material that is desired to be removed from the blood of a patient.
Control profile
Gwangseong Kim from Lexington, MA, age ~51 Get Report